
Last updated: 2026-09-07 17:59:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Baird Medical Investment Holdings Ltd (BDMD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.11, with a market capitalization of $34.86M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.76 to $3.70. This page covers its latest market performance, valuation, price trends and company information.
$34.86M | |
$1.16 | |
$12.50 | |
$0.76 | |
$1.17 | |
32.82K | |
73.31K | |
-- | |
$3.70 | |
$0.76 | |
-- | |
-- |
Baird Medical Investment Holdings Ltd (BDMD) last closed at $1.17 as of 2026-09-05 00:00:00, unchanged from the previous close of $1.17.
During the latest regular trading session, BDMD traded between $0.76 and $12.50, with a volume of 32.82K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Baird Medical Investment Holdings Ltd (BDMD) moved from $1.11 to $1.11, representing no net price change.
The stock traded between $1.06 and $1.21 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 32.56 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 12.0%
BDMD is currently trading at $1.11, placing it 12.0% of the way from its 52-week low of $0.76 to its 52-week high of $3.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
| Employees | 146 |
| Exchange | NASDAQ |
Eligible investors can buy real shares of Baird Medical Investment Holdings Ltd (BDMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.